AstraZeneca to acquire vaccine maker Icosavax in ~$1.1B deal
Published
Published
The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels as part of the coronavirus disease (COVID-19)..
UK pharma group agrees to buy Seattle-based biotech Icosavax
Drugmaker AstraZeneca on Tuesday agreed to buy vaccine developer Icosavax in a deal valued at up to $1.1 billion to bolster its..